肠内餵食设备市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

2024 年全球肠内餵食设备市场价值为 65 亿美元，预计 2025 年至 2034 年的复合年增长率为 5.9%。该领域的成长主要得益于慢性病盛行率的上升、新生儿和早产儿餵食需求的增加以及家庭护理环境中肠内餵食解决方案的广泛采用。随着越来越多的人面临损害其自然进食能力的状况，对这些设备的需求持续上升。肠内餵食对于因医疗状况而无法口服进食的患者提供必需的营养素起着至关重要的作用。接受影响咀嚼或吞嚥能力的治疗的患者依靠这些设备来维持充足的营养。家庭护理由于其成本效益和便利性而正在显着增长。医疗保健提供者越来越多地推荐肠内餵食解决方案来满足短期和长期的营养需求。

肠内餵食设备市场依产品类型分类，包括肠内餵食管、帮浦、注射器、给药装置和配件。预计肠内营养管将引领市场扩张，预计复合年增长率为 5.6%，到 ​​2034 年将达到 47 亿美元以上。这些管子对于为患有各种健康状况的个人提供有针对性的营养至关重要。它们在急性和慢性护理环境中的作用使它们成为确保适当营养的首选解决方案。不同类型的餵食管使得医疗专业人员能够根据患者的个别需求量身订做治疗方案。随着医院、诊所和家庭护理机构的广泛采用，肠内餵食管仍然是市场成长的主要驱动力。

市场也根据患者群体进行细分，包括成人和儿童人群。成人类别占最大份额，预计从 2025 年到 2034 年的复合年增长率为 5.4%。需要肠内营养的成人数量不断增加，导致这些设备的需求持续增加。许多患有长期疾病的成年人需要长期肠内餵食以维持健康并预防併发症。这些解决方案在安宁疗护中的应用越来越广泛，进一步刺激了需求，因为它们在无法进行传统餵食的情况下提供了重要的营养支持。

在应用方面，肠内营养装置广泛应用于各种医疗状况，包括癌症、神经系统疾病和胃肠道疾病。 2024 年，癌症领域占了 47.3% 的市场。许多治疗导致进食困难，因此需要肠内餵食以维持充足的营养。对于需要长期照护的个人，这些设备在确保能量水平保持稳定同时防止进一步併发症方面发挥着至关重要的作用。

市场也按最终用途划分，包括家庭护理、医院和其他设施。家庭护理产业在 2024 年引领市场，预计到 2034 年将达到 57 亿美元。人口老化推动了对家庭肠内营养的需求，使个人能够在保持独立性的同时获得必要的营养支持。与长期住院相比，居家照护由于价格便宜，成为许多患者的首选。随着可近性的提高，更多的人可以从这些解决方案中受益，特别是在自付医疗费用较高的地区。

2024 年美国肠内营养设备市场价值为 19 亿美元，预计到 2034 年将以 5.2% 的复合年增长率成长。老年人口的成长和家庭医疗保健服务的日益普及支持了市场扩张。领先公司的研发努力促进了创新和产品的可用性。优惠的报销政策和政府支持的促进营养疗法的倡议进一步增强了市场成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 慢性病盛行率上升
    • 新生儿和早产儿肠餵食需求增加
    • 居家照护环境中肠内餵食的偏好不断增加
    • 肠内营养装置的技术进步
  • 产业陷阱与挑战
    • 与肠内营养管相关的併发症
    • 严格的政府法规和合规要求
• 成长潜力分析
• 监管格局
• 技术格局
• 报销场景
• 差距分析
• 波特的分析
• PESTEL 分析
• 未来市场趋势

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 肠内营养管
  • 鼻肠管/鼻饲管
    • 鼻胃管
    • 鼻空肠管
  • 腹部/造口饲管
    • 胃造口管
    • 空肠造口/空肠管
    • 胃空肠管 (GJ) 或经空肠管
• 肠内营养泵
• 肠内注射器
• 赠送套装
• 配件

第 6 章：市场估计与预测：按患者，2021 - 2034 年

• 主要趋势
• 成人
• 儿科

第 7 章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 癌症
  • 头颈癌
  • 胃肠道癌症
  • 其他癌症类型
• 中枢神经系统 (CNS) 和心理健康
• 非恶性胃肠道 (GI) 疾病
• 其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2034 年

• 主要趋势
• 居家护理
• 医院
• 其他最终用途

第 9 章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• ALCOR SCIENTIFIC
• Abbott
• AMSINO
• AMT
• - Braun
• Baxter
• Becton Dickinson
• Boston Scientific
• Cardinal Health
• CONMED
• Cook Medical
• DANONE
• FRESENIUS KABI
• HALYARD
• MOOG
• VYGON

The Global Enteral Feeding Devices Market was valued at USD 6.5 billion in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2034. Growth in this sector is driven by the increasing prevalence of chronic illnesses, rising demand for neonatal and preterm feeding, and the expanding adoption of enteral feeding solutions in home care settings. As more individuals face conditions that impair their ability to consume food naturally, the demand for these devices continues to climb. Enteral feeding plays a crucial role in delivering essential nutrients to individuals who cannot eat orally due to medical conditions. Patients undergoing treatments that impact their ability to chew or swallow rely on these devices to maintain adequate nutrition. Home-based care is seeing significant growth due to its cost-effectiveness and convenience. Healthcare providers increasingly recommend enteral feeding solutions for managing both short-term and long-term nutritional needs.

The enteral feeding devices market is categorized based on product type, including enteral feeding tubes, pumps, syringes, giving sets, and accessories. Enteral feeding tubes are expected to lead market expansion with a projected CAGR of 5.6%, reaching over USD 4.7 billion by 2034. These tubes are essential for delivering targeted nutrition to individuals dealing with various health conditions. Their role in acute and chronic care settings makes them a preferred solution for ensuring proper nourishment. The availability of different types of feeding tubes enables healthcare professionals to customize treatments based on individual patient needs. With broad adoption across hospitals, clinics, and home care facilities, enteral feeding tubes remain a primary driver of market growth.

The market is also segmented based on patient groups, including adult and pediatric populations. The adult category holds the largest share and is expected to grow at a CAGR of 5.4% from 2025 to 2034. A rising number of adults requiring enteral nutrition contributes to sustained demand for these devices. Many adults with long-term conditions need enteral feeding for extended periods to maintain health and prevent complications. The increasing adoption of these solutions in palliative care further boosts demand, as they provide vital nutritional support in cases where traditional feeding is not an option.

In terms of application, enteral feeding devices are widely used across various medical conditions, including cancer, neurological disorders, and gastrointestinal diseases. The cancer segment accounted for 47.3% of the market share in 2024. Many treatments lead to difficulties in consuming food, making enteral feeding necessary to maintain adequate nutrition. For individuals requiring long-term care, these devices play an essential role in ensuring energy levels remain stable while preventing further complications.

The market is also divided by end-use, including home care, hospitals, and other facilities. The home care sector led the market in 2024 and is expected to reach USD 5.7 billion by 2034. An aging population drives demand for home-based enteral feeding, allowing individuals to receive necessary nutritional support while maintaining independence. The affordability of home-based care, compared to extended hospital stays, makes it a preferred choice for many patients. With increased accessibility, more individuals can benefit from these solutions, particularly in regions with high out-of-pocket healthcare expenses.

The U.S. enteral feeding devices market was valued at USD 1.9 billion in 2024 and is projected to grow at a CAGR of 5.2% through 2034. A growing elderly population and increasing adoption of home healthcare services support market expansion. Research and development efforts by leading companies contribute to innovation and product availability. Favorable reimbursement policies and government-backed initiatives promoting nutritional therapies further strengthen market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic diseases
    • 3.2.1.2 Increase in demand for neonatal and preterm enteral feeding
    • 3.2.1.3 Surging preference for enteral feeding at home care settings
    • 3.2.1.4 Technological advancements in enteral feeding devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Complications associated with enteral feeding tubes
    • 3.2.2.2 Stringent government regulations and compliance requirements
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Enteral feeding tubes
  • 5.2.1 Nasoenteric/nasal feeding tube
    • 5.2.1.1 Nasogastric tube
    • 5.2.1.2 Nasojejunal tube
  • 5.2.2 Abdominal/ostotomy feeding tube
    • 5.2.2.1 Gastrostomy tube
    • 5.2.2.2 Jejunostomy/jejunal tube
    • 5.2.2.3 Gastrojejunal (GJ) or transjejunal tube
• 5.3 Enteral feeding pumps
• 5.4 Enteral syringes
• 5.5 Giving sets
• 5.6 Accessories

Chapter 6 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Adult
• 6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Cancer
  • 7.2.1 Head and neck cancer
  • 7.2.2 Gastrointestinal cancer
  • 7.2.3 Other cancer types
• 7.3 Central nervous system (CNS) and mental health
• 7.4 Non-malignant gastrointestinal (GI) disorders
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Home care
• 8.3 Hospitals
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ALCOR SCIENTIFIC
• 10.2 Abbott
• 10.3 AMSINO
• 10.4 AMT
• 10.5 - Braun
• 10.6 Baxter
• 10.7 Becton Dickinson
• 10.8 Boston Scientific
• 10.9 Cardinal Health
• 10.10 CONMED
• 10.11 Cook Medical
• 10.12 DANONE
• 10.13 FRESENIUS KABI
• 10.14 HALYARD
• 10.15 MOOG
• 10.16 VYGON